These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10434539)

  • 21. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral manifestations of erythema multiforme.
    Ayangco L; Rogers RS
    Dermatol Clin; 2003 Jan; 21(1):195-205. PubMed ID: 12622281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus.
    Torchia D; Romanelli P; Kerdel FA
    J Am Acad Dermatol; 2012 Sep; 67(3):417-21. PubMed ID: 22101216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poison ivy: an underreported cause of erythema multiforme.
    Werchniak AE; Schwarzenberger K
    J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S159-60. PubMed ID: 15577759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythema multiforme in children versus Stevens-Johnson syndrome].
    Czubkowska I; Barszczak H; Koźniewska D; Wasaznik G
    Wiad Lek; 2000; 53(1-2):43-8. PubMed ID: 10806920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythema multiforme majus (Fuchs syndrome) associated with Mycoplasma pneumoniae infection in two patients.
    Havliza K; Jakob A; Rompel R
    J Dtsch Dermatol Ges; 2009 May; 7(5):445-8. PubMed ID: 19178613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythema multiforme: diagnosis, clinical manifestations and treatment in a retrospective study of 22 patients.
    Sanchis JM; Bagán JV; Gavaldá C; Murillo J; Diaz JM
    J Oral Pathol Med; 2010 Nov; 39(10):747-52. PubMed ID: 20738747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In the pursuit of classifying severe cutaneous adverse reactions.
    Wolf R; Wolf D; Davidovici B
    Clin Dermatol; 2007; 25(3):348-9. PubMed ID: 17560313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)].
    Ludwig C; Brinkmeier T; Frosch PJ
    Dtsch Med Wochenschr; 2003 Mar; 128(10):487-90. PubMed ID: 12627339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [11 cases of erythema multiforme. The etiological correlations and therapy].
    Vescovi P; Zucchi A; Bonanini M; Pizzi S; Gennari PU
    Minerva Stomatol; 1994 Jun; 43(6):301-7. PubMed ID: 7935282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shape and configuration of skin lesions: targetoid lesions.
    Wolf R; Lipozencic J
    Clin Dermatol; 2011; 29(5):504-8. PubMed ID: 21855725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythema multiforme with reference to atypical presentation in an HIV-positive patient following antiretroviral therapy discontinuation.
    Lugović Mihić L; Buljan M; Bulat V; Situm M
    Acta Dermatovenerol Croat; 2009; 17(1):9-15. PubMed ID: 19386210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggers, clinical manifestations, and management of pediatric erythema multiforme: A systematic review.
    Zoghaib S; Kechichian E; Souaid K; Soutou B; Helou J; Tomb R
    J Am Acad Dermatol; 2019 Sep; 81(3):813-822. PubMed ID: 31331726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral erythema multiforme major: a triple case report.
    Brown RS; Farquharson AA; Morton I; Tyler MT
    Gen Dent; 2011; 59(4):302-8. PubMed ID: 21903570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and etiological aspects of erythema multiforme. A propos of 40 cases].
    Maleville J; Massicot P; Ponge A; Guillard JM; Sarrat P; Guillet G
    Sem Hop; 1983 Mar; 59(10):671-5. PubMed ID: 6304887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quadrivalent human papillomavirus vaccine: erythema multiforme and cutaneous side effects after administration.
    Pérez-Carmona L; Aguayo-Leiva I; González-García C; Jaén-Olasolo P
    Dermatology; 2010; 221(3):197-200. PubMed ID: 20861606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythema multiforme. Clinical characteristics and natural history in fifty patients.
    Lozada F; Silverman S
    Oral Surg Oral Med Oral Pathol; 1978 Nov; 46(5):628-36. PubMed ID: 280857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.